外基因介导保护:阻止纤维化的进展
Chuanqi Liu1, Qingfeng Li1, Jian-Xing Ma2
1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
Genes & diseases
|September 12, 2024
概括
来自干细胞的外体细胞显示出通过减少炎症和促进脏组织再生来治疗纤维化的前景. 这些天然纳米粒子在治疗脏疾病方面比干细胞具有优势.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 再生医学是一种再生医学.
- 纳米技术纳米技术
背景情况:
- 纤维化是慢性病 (CKD) 的关键因素,涉及炎症和细胞外基质沉积,导致功能丧失.
- 目前治疗纤维化的疗法提供有限的保护,需要新的治疗策略.
- 干细胞衍生外体正在成为纤维化治疗的有前途的治疗方法.
研究的目的:
- 审查外体的治疗潜力,包括自然和人工变体,用于治疗纤维化.
- 为了比较基于外体的疗法与基于干细胞的疗法,用于脏保护和组织再生.
- 讨论未来的策略,以提高瘤外基疗法在脏疾病的疗效.
主要方法:
- 对外体生物学的当前文献和它们在细胞间通信中的作用的综述.
- 分析使用外体细胞治疗急性损伤 (AKI) 和CKD模型的研究.
- 与干细胞治疗相比,外体细胞治疗的优势 (非免疫性,低瘤风险,易于储存) 的比较.
主要成果:
- 在动物模型中,外体提供治疗分子,可减少炎症,纤维化和细胞外基质的产生.
- 在临床前研究中,外体促进组织再生,并保持功能.
- 基于外体细胞的治疗方法在安全性和实用性方面比传统的干细胞治疗方法具有潜在的优势.
结论:
- 外体代表了一种可行的无细胞治疗策略,用于减轻纤维化和促进脏修复.
- 需要进一步的研究和战略开发,以优化基于外体的疗法,以便在脏疾病中临床应用.
- 外体疗法对改善急性损伤和慢性病患者的治疗结果具有显著的前景.
相关概念视频
Renal Drug Excretion: Tubular Reabsorption
133
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
133
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Drug Elimination by Renal Route: Tubular Reabsorption
3.3K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.3K
Drug Elimination by Renal Route: Glomerular Filtration
5.5K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.5K


